Prelude Capital Management, LLC Kala Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$4.93 - $8.8 $39,997 - $71,394	-8,113 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.19 - $8.97 $42,106 - $72,773	8,113 New	8,113 $67,000
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.49 $944,353 - $1.24 Million	-71,004 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $783,830 - $1.21 Million	63,934 Added 904.3%	71,004 $1.12 Million
Q4 2017 Feb 14, 2018	BUY	$13.68 - $23.17 $96,717 - $163,811	7,070	7,070 $131,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.57M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.